Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT02455076

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02455076
Other papers using this trial's data
  • A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes Diabetes care, 2019-03 DOI, PubMed 30679302, PMC6905476 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02455076. Randomized; no masking; primary purpose treatment. Start 2015-09 (actual); primary completion 2018-03 (actual). Results posted on 2019-06-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
Intervention (Drug)
Exenatide
Intervention (Drug)
Glargine
Intervention (Drug)
Rapid-acting insulin analogs
Lead sponsor
Emory University (class: other)

Record details

Record id
cardio:ct-nct02455076
Content hash
839fb90ad07f03d188d2325fe288279f8eaf4f6dcbccbe1dc343b607ede7edff